...
首页> 外文期刊>Journal of clinical neuroscience: official journal of the Neurosurgical Society of Australasia >Risk factors in development of motor complications in Chinese patients with idiopathic Parkinson's disease.
【24h】

Risk factors in development of motor complications in Chinese patients with idiopathic Parkinson's disease.

机译:中国特发性帕金森病患者运动并发症发展的危险因素。

获取原文
获取原文并翻译 | 示例
           

摘要

Motor complications induced by levodopa (L-dopa) treatment in Parkinson's disease (PD) are not well documented in patients of Chinese ethnicity. We performed a cross-sectional study to investigate the prevalence of dyskinesias and motor fluctuations, and the factors determining their development, in a population of Chinese patients with PD. Among 137 patients with PD, 98 (71.5%) had received a L-dopa preparation. Motor fluctuations were found in 74.5% and dyskinesias in 77.6% of the 98 patients. Patients with dyskinesias were younger at onset of disease than those without. Patients with dyskinesias and motor fluctuations had significantly longer duration of PD and L-dopa treatment, higher daily doses of L-dopa, and higher scores in the 39-item Parkinson's Disease Questionnaire (PDQ-39), when compared to patients without motor complications. Among these factors, motor fluctuations were best predicted by duration of L-dopa treatment and dyskinesias by disease duration. We conclude that motor complications are closely related to disease and treatment parameters, especially the treatment and disease duration.
机译:左旋多巴(L-多巴)治疗帕金森氏病(PD)引起的运动并发症在中国华裔患者中没有得到很好的记录。我们进行了一项横断面研究,以调查中国PD患者人群中的运动障碍和运动波动的患病率以及决定其发展的因素。在137例PD患者中,有98例(71.5%)接受了左旋多巴制剂的治疗。 98例患者中74.5%的运动波动和77.6%的运动障碍。运动障碍的患者比没有运动障碍的患者年轻。与没有运动并发症的患者相比,运动障碍和运动波动患者的PD和L-多巴治疗持续时间明显更长,L-多巴的每日剂量更高,帕金森氏病问卷(PDQ-39)的得分更高(39项) 。在这些因素中,运动波动最好通过左旋多巴治疗的持续时间来预测,运动障碍可以通过疾病的持续时间来预测。我们得出结论,运动并发症与疾病和治疗参数,尤其是治疗和疾病持续时间密切相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号